Skip to content
메만틴

Structure via PubChem · Public domain (PubChem)

EntityQ412189· pop 35· linked from 2,852 articles

Also known as 3,5-dimethyl-1-adamantanamine, 1,3-dimethyl-5-adamantanamine, 3,5-dimethyl-1-aminoadamantane, 3,5-dimethyltricyclo[3.3.1.1(3,7)]decan-1-amine, 1-amino-3,5-dimethyladamantane, 1,3-dimethylaminoadamantane

Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. It is taken by mouth.

In the Vinony graph

Vinony's link graph records 2,852 inbound references to 메만틴, and connects out to agonist, nicotinic acetylcholine receptor and NMDA receptor.

Vinony files it under 5-HT3 antagonists, Adamantanes and Amines.

Vinony links it to 34 Wikipedia language editions.

Chemical data

Formula
C12H21N
Molecular weight
179.3 g/mol
IUPAC name
3,5-dimethyladamantan-1-amine
SMILES
CC12CC3CC(C1)(CC(C3)(C2)N)C
InChIKey
BUGYDGFZZOZRHP-UHFFFAOYSA-N
XLogP
3.3
Polar surface area
26 Ų
H-bond donors
1
H-bond acceptors
1
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
2002
Admin. routes
oral
Indications
autism spectrum disorder, nicotine dependence, autism, pain

via ChEMBL · EBI

Described at

Memantine: a medicine to treat some types of dementia. - NHS

NHS medicines information on memantine – what it's used for, side effects, dosage and who can take it.

nhs.uk →

Link to a page describing this subject · 2,355 chars · not written by Vinony

Wikidata facts

Has part
carbon
Mass
179.1674
Has use
medication
Show 8 more facts
Commons category
Memantine
medical condition treated
Alzheimer's disease
chemical formula
C₁₂H₂₁N
canonical SMILES
CC12CC3CC(C1)(CC(C3)(C2)N)C
World Health Organisation international non-proprietary name
memantine
defined daily dose
40
subject has role
dopaminergic
Sources (7)

via Wikidata · CC0

Connections

Categories